[Retracted] Meta-Analysis of the Effectiveness and Safety of Glucocorticoid for the Treatment of IgA Kidney Disease

Table 2

Effect of glucocorticoid on IgA nephropathy patients with proteinuria less than 1.50 g/d.

Glucocorticoid group				Control group			Std. mean difference
Study or subgroup	Mean	SD	Total	Mean	SD	Total	Weight	IV, fixed, 95% CI
Shoji et al., 2000	0.29	0.23	11	0.71	0.39	8	24.3%	−1.31 [−2.33,−0.29]
Koike et al., 2008	0.31	0.51	24	0.68	0.69	24	75.7%	−0.60 [−1.18,−0.02]
Total (95% CI)			35			32	100.0%	−0.77 [−1.28,−0.27]

Heterogeneity: Chi’ = 1.40, df = 1 ( = 0.24); I² = 29%; test for overall effect: Z = 3.00 ( = 0.003).